Summary graphs presenting the effects estrogen-progesterone, ibandronate, and raloxifene therapies on osteoporosis-related traits across VDR genotypes are provided in the supplementary file (see Supplementary file/Figures S1–S3). This evidence concerns the gene VDR and osteoporosis.